VisualSonics sees 200th install of micro-ultrasound system

Toronto, Ontario-based VisualSonics, a developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, announced that it has sold its 200th VevoT platform.  The company feels that its success is indicative of the significant demand for micro-ultrasound technology within biotechnology, pharmaceutical and medical research organizations. Another sign? The company said that it saw quarterly revenues of a few hundred thousand dollars in 2003. Now VisualSonics is experiencing a 145 percent compounded annual growth rate, quickly reaching its current $24 million in annualized sales, according to a release.

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.